The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The digital therapeutics market will rise from $5.53 billion in 2022 to $6.93 billion in 2023, with a 25.1% CAGR. It’s projected to reach $17.19 billion in 2027, with a 25.5% CAGR.

North America held the largest digital therapeutics market share, and Asia-Pacific was the fastest-growing region in 2022.

Digital Therapeutics Market Driver
The digital therapeutics market is set to grow due to increased smartphone and tablet usage with healthcare apps. These offer benefits like reduced medication errors, enhanced preventive care, and improved staffing. In the US, smartphone users reached 270 million in 2020, with ownership rising from 81% in 2019 to 85% in 2021, a significant increase from 35% in 2011. Hence, rising smartphone adoption fuels digital therapeutics market growth.

View More On The Digital Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/digital-therapeutics-global-market-report

Prominent Digital Therapeutics Market Trend
In the digital therapeutics market, tech innovation is rising. Leading firms aim to enhance their standing by creating advanced digital therapeutic solutions. For instance, Boehringer Ingelheim and Click Pharmaceuticals collaborated in 2020 to create a $500 million mobile app, CT-155, for schizophrenia patients, using Click’s technology platform.

Digital Therapeutics Market Prominent Players
Major players in the digital therapeutics market are Omada Health Inc., WellDoc Inc., 2Morrow Inc., Livongo Health, Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Mango Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic PLC., Teladoc Health Inc., and Fitbit Health Solutions.

Request A Sample Of The Global Digital Therapeutics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5343&type=smp

Key Digital Therapeutics Market Segments
The global digital therapeutics market is segmented –
1) By Product: Software, Devices
2) By Sales Channel: Business-To-Business (B2B), Business-To-Consumers (B2C)
3) By Application: Preventive Applications, Treatment Or Care-Related Applications

The Digital Therapeutics Global Market Report 2023  provides a comprehensive overview on the digital therapeutics market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the digital therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Neurodegenerative Disorder Therapeutics Global Market Report 2023
Antisense & RNAi Therapeutics Global Market Report 2023
Leukemia Therapeutics Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model